Boundless Bio, Inc. (BOLD) vs ImageneBio Inc (IMA)
A side-by-side comparison of Boundless Bio, Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.59HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
IMA
ImageneBio Inc
$4.72HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
Total return — BOLD vs IMA
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)IMA -72.4% (-34.9%/yr)IMA compounded faster over this window
BOLD IMA
BOLD vs IMA: by the numbers
- •BOLD is the larger company ($58M vs $53M market cap).
- •Both run net losses; BOLD's is the smaller (0.00% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | BOLD | IMA |
|---|---|---|
| P/B ratio | 0.88 | 0.37 |
Profitability
| Metric | BOLD | IMA |
|---|---|---|
| Gross margin | 0.00% | -29.12% |
| Operating margin | 0.00% | -6056.37% |
| Net margin | 0.00% | -5668.62% |
| ROE | -58.99% | -36.94% |
| ROIC | -43.97% | -40.53% |
Growth (annualized)
| Metric | BOLD | IMA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -50.73% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.